Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Parkinson's Disease

  Free Subscription


2 BMC Neurol
1 J Neurochem
3 Mov Disord
1 Neurol Genet
3 Neurology
1 Neurosci Lett
1 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Neurol

  1. HU L, Shi Y, Zou X, Lai Z, et al
    Association of time spent outdoors with the risk of Parkinson's disease: a prospective cohort study of 329,359 participants.
    BMC Neurol. 2024;24:10.
    PubMed         Abstract available

  2. VAN DER STAM AH, de Vries NM, Shmuely S, Smeenk D, et al
    Study protocol for the Heads-Up trial: a phase II randomized controlled trial investigating head-up tilt sleeping to alleviate orthostatic intolerance in Parkinson's Disease and parkinsonism.
    BMC Neurol. 2024;24:4.
    PubMed         Abstract available

    J Neurochem

  3. CARMONA A, Carboni E, Gomes LC, Roudeau S, et al
    Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis.
    J Neurochem. 2024 Jan 5. doi: 10.1111/jnc.16040.
    PubMed         Abstract available

    Mov Disord

  4. AMMANN C, Oliviero A, Obeso JA, Foffani G, et al
    Motor Cortex Disinhibition Is Not Associated with Freezing of Gait in Parkinson's Disease.
    Mov Disord. 2024 Jan 5. doi: 10.1002/mds.29709.

  5. THOMAS GEC, Hannaway N, Zarkali A, Shmueli K, et al
    Longitudinal Associations of Magnetic Susceptibility with Clinical Severity in Parkinson's Disease.
    Mov Disord. 2024 Jan 3. doi: 10.1002/mds.29702.
    PubMed         Abstract available

  6. SICILIANO M, Tessitore A, Morgante F, Goldman JG, et al
    Subjective Cognitive Complaints in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Mov Disord. 2024 Jan 3. doi: 10.1002/mds.29649.
    PubMed         Abstract available

    Neurol Genet

  7. PARK M, Lee YG
    Association of Family History and Polygenic Risk Score With Longitudinal Prognosis in Parkinson Disease.
    Neurol Genet. 2023;10:e200115.
    PubMed         Abstract available


  8. KAHLON S, Barton CR, Abu Libdeh A, O'Malley JA, et al
    Emerging Subspecialties: Pediatric Movement Disorders Neurology.
    Neurology. 2024;102:e208050.
    PubMed         Abstract available

  9. ELLIOTT JE, Bryant-Ekstrand MD, Keil AT, Ligman BR, et al
    Frequency of Orthostatic Hypotension in Isolated REM Sleep Behavior Disorder.
    Neurology. 2023;101:e2545-e2559.
    PubMed         Abstract available

    How Certain Are You When Making the Diagnosis of Multiple System Atrophy?
    Neurology. 2023;101:1081-1082.
    PubMed         Abstract available

    Neurosci Lett

  11. HU Q, Xu L, Liu X, Wang Y, et al
    Adenosine A(2A) receptor antagonist KW6002 protects against A53T mutant alpha-synuclein-induced brain damage and neuronal apoptosis in Parkinson's disease mice by restoring autophagic flux.
    Neurosci Lett. 2023 Dec 27:137610. doi: 10.1016/j.neulet.2023.137610.
    PubMed         Abstract available

    PLoS One

  12. KIM M, Kim D, Kang H, Park S, et al
    A machine learning model for prediction of sarcopenia in patients with Parkinson's Disease.
    PLoS One. 2024;19:e0296282.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  13. AUBREY LD, Ninkina N, Ulamec SM, Abramycheva NY, et al
    Substitution of Met-38 to Ile in gamma-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid.
    Proc Natl Acad Sci U S A. 2024;121:e2309700120.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.